Connection

Alessandro Armuzzi to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Alessandro Armuzzi has written about Antibodies, Monoclonal.
Alessandro Armuzzi
Connection Strength
0.054
Antibodies, Monoclonal
  1. The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar. Inflamm Bowel Dis. 2017 02; 23(2):233-243.
    View in: PubMed
    Score: 0.042
  2. Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study. Dig Liver Dis. 2019 04; 51(4):510-515.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.